PB-22
化合物
PB-22是一种狡诈家药物,化学式为C23H22N2O2,它在网络上作为大麻模拟剂供应,并在2013年于日本的合成大麻产品被发现。[1][2]PB-22在其吲哚环的3号位有酯基,可以被视作一类具有独特结构的合成大麻素。它在2014年于新西兰[3]、同年于美国管控。[4][5]
法律规范状态 | |
---|---|
法律规范 |
|
识别信息 | |
| |
CAS号 | 1400742-17-7 |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.233.114 |
化学信息 | |
化学式 | C23H22N2O2 |
摩尔质量 | 358.44 g·mol−1 |
3D模型(JSmol) | |
| |
|
参考文献
- ^ Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicology. 2013, 31 (2): 223–240. S2CID 1279637. doi:10.1007/s11419-013-0182-9.
- ^ Lin M, Ellis B, Eubanks LM, Janda KD. Pharmacokinetic Approach to Combat the Synthetic Cannabinoid PB-22. ACS Chemical Neuroscience. July 2021, 12 (14): 2573–2579. PMID 34254505. S2CID 235808519. doi:10.1021/acschemneuro.1c00360.
- ^ Jones N. Legal highs pulled from shelves. New Zealand Herald. New Zealand Media and Entertainment. 1 May 2014 [18 August 2020]. (原始内容存档于2017-12-01).
- ^ Behonick G, Shanks KG, Firchau DJ, Mathur G, Lynch CF, Nashelsky M, et al. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. Journal of Analytical Toxicology. October 2014, 38 (8): 559–562. PMC 4334789 . PMID 24876364. doi:10.1093/jat/bku048.
- ^ PB-22 and 5F-PB-22 (PDF). DEA, Office of Diversion Control. [2023-11-24]. (原始内容存档 (PDF)于2024-05-21).